$ALKS: USPTO to review Alkermes Vivitrol patent

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Seeking Alpha (https://seekingalpha.com)

Summary: Alkermes plc (NASDAQ:ALKS) discloses that the USPTO’s Patent Trial and Appeal Board will allow an inter partes review of 13 claims of its U.S. Patent No.

Full article address: https://seekingalpha.com/news/3408334-uspto-review-alkermes-vivitrol-patent

Related News:

$ALKS: EQUITY ALERT: Rosen Law Firm Announces Investigation of …

$ALKS: Just How Bad Is Alkermes’ Depression Drug Setback?

$ALKS: Why Alkermes’ Depression Drug Stumbled, and How Illumina Plans …

$ALKS: Why the FDA Is Dragging Alkermes Down

$ALKS: Alkermes Is Making All The Right Moves In 2018

$ALKS: Alkermes Reports on Outcome of FDA Advisory Committee Meeting …

$ALKS: Alkermes shares halted

$ALKS: Alkermes down 6% premarket ahead of Ad Com for buprenorphine …

$ALKS: Alkermes (ALKS) CEO Richard Pops on Q3 2018 Results – Earnings …

$ALKS: Alkermes PLC (ALKS) Q3 2018 Earnings Conference Call Transcript

$ALKS: Alkermes Q3 Earnings Preview

Latest News:

$SPCB: SuperCom, Ltd. (SPCB) CEO Arie Trabelsi on Q3 2018 Results …

$NXTD: NXT-ID Inc. (NXTD) CEO Gino Pereira on Q3 2018 Results …

$LOW: Lowe’s Looks to Start Catching Up With Home Depot

$VIPS: Vipshop Holdings (VIPS) CEO Eric Shen on Q3 2018 Results …

$EA $AMZN $DIS $MSFT $TXN $XLNX: What We Learned from Microsoft, EA, TI and Booking’s Earnings Calls

$V $WYNN $TGT $OPK $BBBY $PANW: Visa, Wynn Resorts, Target: ‘Mad Money’ Lightning Round

$FIT: INVESTIGATION ALERT REMINDER: The Schall Law Firm …

$MNGA: MagneGas Corporation (MNGA) CEO Scott Mahoney on Q3 2018 …

$TGTX: Glancy Prongay & Murray LLP Announces the Filing of a Securities …

$SNDE: Sundance Energy Australia (SNDE) CEO Eric McCrady on Q3 2018 …

$FIT: Why Fitbit Is Down 1% So Far in 2018